These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31183542)

  • 1. Reorganization of the nuclear compartments involved in transcription and RNA processing in myonuclei of type I spinal muscular atrophy.
    Castillo-Iglesias MS; Berciano MT; Narcis JO; Val-Bernal JF; Rodriguez-Rey JC; Tapia O; Lafarga M
    Histochem Cell Biol; 2019 Sep; 152(3):227-237. PubMed ID: 31183542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reorganization of Cajal bodies and nucleolar targeting of coilin in motor neurons of type I spinal muscular atrophy.
    Tapia O; Bengoechea R; Palanca A; Arteaga R; Val-Bernal JF; Tizzano EF; Berciano MT; Lafarga M
    Histochem Cell Biol; 2012 May; 137(5):657-67. PubMed ID: 22302308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular bases of the RNA metabolism dysfunction in motor neurons of a murine model of spinal muscular atrophy: Role of Cajal bodies and the nucleolus.
    Tapia O; Narcís JO; Riancho J; Tarabal O; Piedrafita L; Calderó J; Berciano MT; Lafarga M
    Neurobiol Dis; 2017 Dec; 108():83-99. PubMed ID: 28823932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mislocalization of SMN from the I-band and M-band in human skeletal myofibers in spinal muscular atrophy associates with primary structural alterations of the sarcomere.
    Berciano MT; Castillo-Iglesias MS; Val-Bernal JF; Lafarga V; Rodriguez-Rey JC; Lafarga M; Tapia O
    Cell Tissue Res; 2020 Sep; 381(3):461-478. PubMed ID: 32676861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
    J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An essential SMN interacting protein (SIP1) is not involved in the phenotypic variability of spinal muscular atrophy (SMA).
    Helmken C; Wetter A; Rudnik-Schöneborn S; Liehr T; Zerres K; Wirth B
    Eur J Hum Genet; 2000 Jul; 8(7):493-9. PubMed ID: 10909848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene.
    Zarkov M; Stojadinović A; Sekulić S; Barjaktarović I; Perić S; Keković G; Drasković B; Stević Z
    Vojnosanit Pregl; 2015 Oct; 72(10):859-63. PubMed ID: 26665550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals.
    Hahnen E; Forkert R; Marke C; Rudnik-Schöneborn S; Schönling J; Zerres K; Wirth B
    Hum Mol Genet; 1995 Oct; 4(10):1927-33. PubMed ID: 8595417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Japanese Patients With SMA Type 1 Suggest that Axonal-SMN May Not Modify the Disease Severity.
    Yamada H; Nishida Y; Maihara T; Sa'adah N; Harahap NI; Nurputra DK; Ar Rochmah M; Nishimura N; Saito T; Kubo Y; Saito K; Nishio H
    Pediatr Neurol; 2015 Jun; 52(6):638-41. PubMed ID: 25838041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gene copy ratios of SMN1/SMN2 in Japanese carriers with type I spinal muscular atrophy.
    Diep Tran T; Kroepfl T; Saito M; Nagura M; Ichiseki H; Kubota M; Toda T; Sakakihara Y
    Brain Dev; 2001 Aug; 23(5):321-6. PubMed ID: 11504604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of neuropathophysiology in spinal muscular atrophy type I.
    Harding BN; Kariya S; Monani UR; Chung WK; Benton M; Yum SW; Tennekoon G; Finkel RS
    J Neuropathol Exp Neurol; 2015 Jan; 74(1):15-24. PubMed ID: 25470343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells.
    Yuo CY; Lin HH; Chang YS; Yang WK; Chang JG
    Ann Neurol; 2008 Jan; 63(1):26-34. PubMed ID: 17924536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical and genetic study of spinal muscular atrophy.
    Mishra VN; Kalita J; Kesari A; Mitta B; Shankar SK; Misra UK
    Electromyogr Clin Neurophysiol; 2004; 44(5):307-12. PubMed ID: 15378871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III.
    Jablonka S; Schrank B; Kralewski M; Rossoll W; Sendtner M
    Hum Mol Genet; 2000 Feb; 9(3):341-6. PubMed ID: 10655542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Securinine enhances SMN2 exon 7 inclusion in spinal muscular atrophy cells.
    Chen YC; Chang JG; Liu TY; Jong YJ; Cheng WL; Yuo CY
    Biomed Pharmacother; 2017 Apr; 88():708-714. PubMed ID: 28152480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients.
    Andreassi C; Jarecki J; Zhou J; Coovert DD; Monani UR; Chen X; Whitney M; Pollok B; Zhang M; Androphy E; Burghes AH
    Hum Mol Genet; 2001 Nov; 10(24):2841-9. PubMed ID: 11734549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect.
    Gavrilina TO; McGovern VL; Workman E; Crawford TO; Gogliotti RG; DiDonato CJ; Monani UR; Morris GE; Burghes AH
    Hum Mol Genet; 2008 Apr; 17(8):1063-75. PubMed ID: 18178576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of 83 cases with spinal muscular atrophy in children].
    Li H; Wang HL; Shan CM
    Zhonghua Er Ke Za Zhi; 2004 Oct; 42(10):762-4. PubMed ID: 16221347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of proximal autosomal recessive spinal muscular atrophy.
    Simic G
    Acta Neuropathol; 2008 Sep; 116(3):223-34. PubMed ID: 18629520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
    Tseng YT; Chen CS; Jong YJ; Chang FR; Lo YC
    Pharmacol Res; 2016 Sep; 111():58-75. PubMed ID: 27241020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.